GeneDx Holdings Corp. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- GeneDx Holdings Corp. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- GeneDx Holdings Corp. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $58.00K, a 92.11% decline year-over-year.
- GeneDx Holdings Corp. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $1.04M, a 607.48% increase year-over-year.
- GeneDx Holdings Corp. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $182.00K, a 111.63% increase year-over-year.
- GeneDx Holdings Corp. stock issued during period, value, stock options exercised for fiscal 2025 was $2.02M, a 413.20% increase from fiscal 2024.
- GeneDx Holdings Corp. stock issued during period, value, stock options exercised for fiscal 2024 was $394.00K, a 38.25% increase from fiscal 2023.
- GeneDx Holdings Corp. stock issued during period, value, stock options exercised for fiscal 2023 was $285.00K, a 90.33% decline from fiscal 2022.
- GeneDx Holdings Corp. stock issued during period, value, stock options exercised for fiscal 2022 was $2.95M, a 65.34% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $1.28M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $58.00K 10-Q · filed 2026-05-04 | $1.34M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $2.02M 10-K · filed 2026-02-23 |
| 2025-09-30 | $182.00K 10-Q · filed 2025-10-28 | $1.13M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $65.00K 10-Q · filed 2026-08-03 | $1.03M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $735.00K 10-Q · filed 2026-05-04 | $1.10M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $147.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $394.00K 10-K · filed 2026-02-23 |
| 2024-09-30 | $86.00K 10-Q · filed 2025-10-28 | $266.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | $137.00K 10-Q · filed 2025-07-29 | $181.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | $24.00K 10-Q · filed 2025-04-30 | $44.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $285.00K 10-K · filed 2026-02-23 |
| 2023-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $1.02M derived: sum of 4 quarters · filed 2024-10-29 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-08 | $1.34M derived: sum of 4 quarters · filed 2024-04-29 |
| 2023-03-31 | $266.00K 10-Q · filed 2024-04-29 | $2.54M derived: sum of 4 quarters · filed 2024-04-29 |
| 2022-12-31 | $750.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $2.95M 10-K · filed 2024-02-23 |
| 2022-09-30 | $329.00K 10-Q · filed 2023-11-03 | $2.50M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $1.19M 10-Q · filed 2023-08-08 | $2.17M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $678.00K 10-Q · filed 2023-05-09 | $2.46M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $1.78M 10-K · filed 2023-03-16 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | |
| 2021-06-30 | $1.48M 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |